サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446448

CRMデバイス（心調律管理装置）の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント別予測、2024年～2030年

Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report By Products (Pacemakers (Implantable, External), Defibrillators, Cardiac Resynchronization Therapy), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
CRMデバイス（心調律管理装置）の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年02月01日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

CRMデバイス（心調律管理装置）市場の成長と動向：

Grand View Research社の最新レポートによると、世界のCRMデバイス市場規模は2030年までに294億6,000万米ドルに達すると予測されています。

同市場は、2024年から2030年にかけて6.9%の有利なCAGRで拡大する見込みです。市場を牽引する主な要因には、心血管障害の有病率増加に起因する心臓リズム管理（CRM）機器の採用拡大が含まれます。米国疾病予防管理センター（CDC）によると、2021年9月現在、毎年約65万9000人の米国人が心臓病を患って死亡しています。COVID-19パンデミック時には、必須ではない心血管系処置を含む選択的処置が延期または中止されたため、市場はマイナスの影響を受けました。

メドトロニック、アボット、ボストン・サイエンティフィック・コーポレーションなど市場の主要企業は、心臓リズム管理事業で世界的に巨額の損失を被りました。その結果、2020年の市場はマイナス成長となりました。突然の心停止に対処する需要の高まりは、あらゆる種類の心臓リズム管理機器の技術革新につながっています。植え込み型デバイスに関する技術革新には、皮下デバイスや経静脈デバイスなど、患者の快適性レベルを高めることを目的とした製品も含まれます。スウェーデン運輸庁は、ドローンを使ってAEDを届けることを目的とした試験段階のプログラムを実施しました。これにより、AEDの配送時間が短縮され、迅速な治療で生存の可能性が高まる可能性があります。

したがって、技術的進歩と製品革新により、市場は成長すると予想されます。革命的な技術進歩の兆しは、市場を急速に変化させています。こうした拡大が有利な可能性を生み出しています。大手企業による研究開発費の増加と新製品の発売が、さらに成長を後押ししています。例えば、2020年10月、アボット社はインドで新しいICDとCRT-Dを発売し、同国での製品ポートフォリオを拡大しました。また、同社は2020年2月にGallant ICDおよびCRT-DデバイスのCEマーク承認を取得しています。こうした要因が市場の成長を後押ししています。主要な市場プレーヤーは、幅広い製品を提供しているため、市場で大きなシェアを占めています。

CRMデバイス市場レポートハイライト

  • 2023年の市場規模は185億7,000万米ドルで、予測期間中にCAGR 6.9％で拡大する見込み。
  • 製品別では、除細動器が世界の採用率の高さから、2023年に39.39%超のシェアで市場を独占しました。
  • 体外式除細動器分野では、自動体外式除細動器分野が、ペーシング、すなわち心臓収縮を刺激するパルス電流の供給や、不整脈や頻脈を正常な心拍に変換する除細動などの関連する利点により、最も高い収益シェアを占めました。
  • 2023年には、北米が心血管疾患の有病率の上昇とCRM機器の高い普及率により、市場で圧倒的なシェアを占めました。
  • アジア太平洋地域は、中国やインドなどの新興国の存在により、予測期間中に有利な成長を示すと予想されます。

目次

第1章 調査手法と範囲

第2章 CRMデバイス市場：エグゼクティブサマリー

  • 市場スナップショット
  • 製品のスナップショット
  • 競合情勢のスナップショット

第3章 CRMデバイス市場：変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
  • 市場促進要因分析
    • 心血管疾患の有病率の増加
    • 低侵襲処置に対する嗜好の増加
  • 市場抑制要因分析
    • デバイスに関連する高コスト
  • CRMデバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析
    • 価格分析

第4章 CRMデバイス：製品の推定・動向分析

  • 製品の市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 製品別の世界のCRMデバイス市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
    • ペースメーカー
    • 除細動器
    • CRT

第5章 地域のビジネス分析

  • 地域の市場シェア分析、2023年および2030年
  • 地域の市場ダッシュボード
  • 世界の地域の市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年まで
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • タイ
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業別の最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • Physio-Control, Inc.
    • Medtronic, plc
    • ABBOTT
    • Boston Scientific Corporation
    • Schiller
    • Koninklijke Philips NV
    • Biotronik
    • Progetti Srl
    • Zoll Medical Corporation
    • LivaNova Plc
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Canada Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Europe Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 7 Europe Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 UK Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 Germany Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 France Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Italy Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 Spain Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 Sweden Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 Norway Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Denmark Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Japan Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 China Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 India Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Australia Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 South Korea Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Thailand Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Latin America Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 25 Latin America Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Brazil Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Mexico Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 Argentina Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 MEA Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
  • Table 30 MEA Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 South Africa Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 UAE Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews in North America
  • Fig. 5 Primary Interviews in Europe
  • Fig. 6 Primary Interviews in APAC
  • Fig. 7 Primary Interviews in Latin America
  • Fig. 8 Primary Interviews in MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-chain-based Sizing & Forecasting
  • Fig. 11 QFD Modeling for Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Cardiac Rhythm Management Devices Market: Market Outlook
  • Fig. 14 Cardiac Rhythm Management Devices Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Cardiac Rhythm Management Devices Market Driver Impact
  • Fig. 20 Cardiac Rhythm Management Devices Market Restraint Impact
  • Fig. 21 Cardiac Rhythm Management Devices Market Strategic Initiatives Analysis
  • Fig. 22 Cardiac Rhythm Management Devices Market: Product Movement Analysis
  • Fig. 23 Cardiac Rhythm Management Devices Market: Product Outlook and Key Takeaways
  • Fig. 24 Pacemakers Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Defibrillators Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Cardiac Resynchronization Therapy (CRT) Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Global Cardiac Rhythm Management Devices Market: Regional Movement Analysis
  • Fig. 28 Global Cardiac Rhythm Management Devices Market: Regional Outlook and Key Takeaways
  • Fig. 29 Global Cardiac Rhythm Management Devices Market Share and Leading Players
  • Fig. 30 North America Market Share and Leading Players
  • Fig. 31 Europe Market Share and Leading Players
  • Fig. 32 Asia Pacific Market Share and Leading Players
  • Fig. 33 Latin America Market Share and Leading Players
  • Fig. 34 Middle East & Africa Market Share and Leading Players
  • Fig. 35 North America, By Country
  • Fig. 36 North America
  • Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 U.S.
  • Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Canada
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Europe
  • Fig. 43 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 UK
  • Fig. 45 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Germany
  • Fig. 47 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 France
  • Fig. 49 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Italy
  • Fig. 51 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Spain
  • Fig. 53 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Denmark
  • Fig. 55 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Sweden
  • Fig. 57 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Norway
  • Fig. 59 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 China
  • Fig. 63 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Japan
  • Fig. 65 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 India
  • Fig. 67 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 Thailand
  • Fig. 69 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 South Korea
  • Fig. 71 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 72 Australia
  • Fig. 73 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 74 Latin America
  • Fig. 75 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 76 Brazil
  • Fig. 77 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 78 Mexico
  • Fig. 79 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 80 Argentina
  • Fig. 81 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 82 Middle East and Africa
  • Fig. 83 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 84 South Africa
  • Fig. 85 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 86 Saudi Arabia
  • Fig. 87 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 88 UAE
  • Fig. 89 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 90 Kuwait
  • Fig. 91 Kuwait Market Estimates and Forecasts, 2018 - 2030
  • Fig. 92 Market Share of Key Market Players- Cardiac Rhythm Management Devices Market
目次
Product Code: GVR-2-68038-315-7

Cardiac Rhythm Management Devices Market Growth & Trends:

The global cardiac rhythm management devices market size is anticipated to reach USD 29.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.9% from 2024 to 2030. The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), as of September 2021, approximately 659,000 Americans die suffering from heart disease every year. The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic.

Major players in the market such as Medtronic; Abbott; and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020. The rising demand for handling sudden cardiac arrests is leading to innovation in all types of cardiac rhythm management devices. Innovation with regards to implantable devices includes products, such as subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment.

Therefore, the market is anticipated to grow because of technological advancements and product innovations. Revolutionary technological signs of progress are rapidly transforming the market. These expansions are producing lucrative potentials. An increase in R&D expenditure and new product launches by leading firms further fueled the growth. For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, hence expanding its product portfolio in the country. The company had also received CE Mark approval for its Gallant ICD and CRT-D devices in February 2020. Such factors boost market growth. Key market players account for a significant share of the market owing to their extensive product offerings.

Cardiac Rhythm Management Devices Market Report Highlights:

  • The market was valued at USD 18.57 billion in 2023 and is expected to expand at a CAGR of 6.9% during the forecast period
  • By product, defibrillators dominated the market with a share of over 39.39% in 2023 due to their high adoption globally
  • In the external defibrillator segment, the automatic external defibrillator segment held the highest revenue share owing to associated benefits, including pacing, i.e., delivering pulses of the current to stimulate heart contraction as well as cardioversion, converting arrhythmia or tachycardia to a normal heartbeat
  • In 2023, North America held the dominant share of the market owing to the rising prevalence of cardiovascular diseases and high adoption of CRM devices
  • Asia Pacific region is expected to show lucrative growth over the forecast period owing to the presence of emerging countries such as China and India

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. Cardiac Rhythm Management Devices Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cardiac Rhythm Management Devices Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Growing prevalence of cardiovascular disease
    • 3.4.2. Increasing preference for minimally invasive procedures
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost associated with the devices
  • 3.6. Cardiac Rhythm Management Devices Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat Of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Technological Landscape
      • 3.6.2.3. Economic Landscape
    • 3.6.3. Pricing Analysis

Chapter 4. Cardiac Rhythm Management Devices: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Cardiac Rhythm Management Devices Market By Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For the Following
    • 4.4.1. Pacemakers
      • 4.4.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.1.1.1. Implantable
      • 4.4.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.1.1.2. External
      • 4.4.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.2. Defibrillators
      • 4.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1. Implantable Cardioverter Defibrillators (ICD)
      • 4.4.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1.1.1. S-ICD
      • 4.4.2.1.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.1.1.2. T-ICD
      • 4.4.2.1.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2. External Defibrillator
      • 4.4.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.1. Manual External Defibrillator
      • 4.4.2.1.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.2. Automatic External Defibrillator
      • 4.4.2.1.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.2.1.2.1.3. Wearable Cardioverter Defibrillator
      • 4.4.2.1.2.1.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 4.4.3. Cardiac Resynchronization Therapy (CRT)
      • 4.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.3.1.1. CRT-Defibrillator
      • 4.4.3.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 4.4.3.1.2. CRT-Pacemakers
      • 4.4.3.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 5.5. North America
    • 5.5.1. U.S.
      • 5.5.1.1. Key Country Dynamics
      • 5.5.1.2. Competitive Scenario
      • 5.5.1.3. Regulatory Framework
      • 5.5.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.5.2. Canada
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. UK
      • 5.6.1.1. Key Country Dynamics
      • 5.6.1.2. Competitive Scenario
      • 5.6.1.3. Regulatory Framework
      • 5.6.1.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.2. Germany
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.3. Spain
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.6. Denmark
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Competitive Scenario
      • 5.6.6.3. Regulatory Framework
      • 5.6.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
      • 5.6.6.5.
    • 5.6.7. Sweden
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Competitive Scenario
      • 5.6.7.3. Regulatory Framework
      • 5.6.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.6.8. Norway
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Competitive Scenario
      • 5.6.8.3. Regulatory Framework
      • 5.6.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key Country Dynamics
      • 5.7.1.2. Competitive Scenario
      • 5.7.1.3. Regulatory Framework
      • 5.7.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.4. South Korea
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.5. Thailand
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.7.6. Australia
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory Framework
      • 5.7.6.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key Country Dynamics
      • 5.8.1.2. Competitive Scenario
      • 5.8.1.3. Regulatory Framework
      • 5.8.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.8.2. Mexico
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory Framework
      • 5.8.2.4. Mexico Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory Framework
      • 5.8.3.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. MEA Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Competitive Scenario
      • 5.9.2.3. Regulatory Framework
      • 5.9.2.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Competitive Scenario
      • 5.9.3.3. Regulatory Framework
      • 5.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Competitive Scenario
      • 5.9.4.3. Regulatory Framework
      • 5.9.4.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Competitive Scenario
      • 5.9.5.3. Regulatory Framework
      • 5.9.5.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company /Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of Key Distributors And Channel Partners
    • 6.3.2. Key Customers
    • 6.3.3. Key Company Market Share Analysis, 2023
    • 6.3.4. Physio-Control, Inc.
      • 6.3.4.1. Overview
      • 6.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.4.3. Product Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Medtronic, plc
      • 6.3.5.1. Overview
      • 6.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.5.3. Product Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. ABBOTT
      • 6.3.6.1. Overview
      • 6.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.6.3. Product Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Boston Scientific Corporation
      • 6.3.7.1. Overview
      • 6.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.7.3. Product Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Schiller
      • 6.3.8.1. Overview
      • 6.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.8.3. Product Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Koninklijke Philips N.V
      • 6.3.9.1. Overview
      • 6.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.9.3. Product Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Biotronik
      • 6.3.10.1. Overview
      • 6.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.10.3. Product Benchmarking
      • 6.3.10.4. Strategic Initiatives
    • 6.3.11. Progetti Srl
      • 6.3.11.1. Overview
      • 6.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.11.3. Product Benchmarking
      • 6.3.11.4. Strategic Initiatives
    • 6.3.12. Zoll Medical Corporation
      • 6.3.12.1. Overview
      • 6.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.12.3. Product Benchmarking
      • 6.3.12.4. Strategic Initiatives
    • 6.3.13. LivaNova Plc
      • 6.3.13.1. Overview
      • 6.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.3.13.3. Product Benchmarking
      • 6.3.13.4. Strategic Initiatives